| AUC | Area Under the Curve |
| BA | Bioavailability |
| BE | Bioequivalence |
| BRI | Biopharmaceutics Research Institute |
| CHMP | Committee for Medicinal Products for Human Use |
| Cmax | Maximum Concentration |
| DPK | Dermatopharmacokinetics |
| EMA | European Medicines Agency |
| Emax | Maximum Effect Model |
| FDA | United States Food and Drug Administration |
| FS | Fraction Absorbed into Skin |
| HSBA | Human Skin Blanching Assay |
| HPLC | High Performance Liquid Chromatography |
| Kin | Rate of Drug Input into the Skin |
| MHLW | Ministry of Health, Labour and Welfare (Japan) |
| MLEM | Maximum Likelihood Expectation Maximization |
| PK | Pharmacokinetics |
| SC | Stratum Corneum |
| TEWL | Transepidermal Water Loss |
| TS | Tape Stripping |